Alexander Gilman
Examiner (ID: 6523, Phone: (571)272-2004 , Office: P/2831 )
Most Active Art Unit | 2833 |
Art Unit(s) | 2833, 2831 |
Total Applications | 3105 |
Issued Applications | 2518 |
Pending Applications | 101 |
Abandoned Applications | 486 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15814053
[patent_doc_number] => 10632183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Methods and compositions employing immunogenic fusion proteins
[patent_app_type] => utility
[patent_app_number] => 15/812361
[patent_app_country] => US
[patent_app_date] => 2017-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 23964
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15812361
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/812361 | Methods and compositions employing immunogenic fusion proteins | Nov 13, 2017 | Issued |
Array
(
[id] => 15527199
[patent_doc_number] => 20200055905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => Bacteriocin Production, Compositions and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 16/347407
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347407
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347407 | Bacteriocin production, compositions and methods of use | Nov 6, 2017 | Issued |
Array
(
[id] => 12710986
[patent_doc_number] => 20180128828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => DIRECT DETECTION OF MICROORGANISMS IN PATIENT SAMPLES BY IMMUNOASSAY
[patent_app_type] => utility
[patent_app_number] => 15/803420
[patent_app_country] => US
[patent_app_date] => 2017-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15803420
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/803420 | DIRECT DETECTION OF MICROORGANISMS IN PATIENT SAMPLES BY IMMUNOASSAY | Nov 2, 2017 | Abandoned |
Array
(
[id] => 15041371
[patent_doc_number] => 20190331690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => BIOTHIOL DETECTION COMPOSITION COMPRISING REDOX REGULATION PROTENIN
[patent_app_type] => utility
[patent_app_number] => 16/347321
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347321
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347321 | BIOTHIOL DETECTION COMPOSITION COMPRISING REDOX REGULATION PROTENIN | Nov 1, 2017 | Abandoned |
Array
(
[id] => 18384526
[patent_doc_number] => 11655298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Composition for treating fulminant acute pneumonia including CD69 antagonist
[patent_app_type] => utility
[patent_app_number] => 16/342992
[patent_app_country] => US
[patent_app_date] => 2017-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 11832
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16342992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/342992 | Composition for treating fulminant acute pneumonia including CD69 antagonist | Oct 19, 2017 | Issued |
Array
(
[id] => 15819023
[patent_doc_number] => 10634685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Pneumococcal serotypes
[patent_app_type] => utility
[patent_app_number] => 15/723136
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17374
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15723136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/723136 | Pneumococcal serotypes | Oct 1, 2017 | Issued |
Array
(
[id] => 12177468
[patent_doc_number] => 20180036402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'IMMUNOGENIC COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/705873
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 35063
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705873
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705873 | IMMUNOGENIC COMPOSITIONS | Sep 14, 2017 | Abandoned |
Array
(
[id] => 17533640
[patent_doc_number] => 20220112249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => MODIFIED FACTOR H BINDING PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/328340
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328340 | MODIFIED FACTOR H BINDING PROTEIN | Aug 30, 2017 | Pending |
Array
(
[id] => 12137073
[patent_doc_number] => 20180015157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'Attenuated Pasteurella Multocida Vaccines & Methods of Making & Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/668946
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10825
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15668946
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/668946 | Attenuated | Aug 3, 2017 | Issued |
Array
(
[id] => 17095443
[patent_doc_number] => 20210283234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => ENGINEERED SALMONELLA SEROVAR TYPHIMURIUM STRAINS, COMPOSITIONS THEREOF, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/321795
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321795
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321795 | ENGINEERED SALMONELLA SEROVAR TYPHIMURIUM STRAINS, COMPOSITIONS THEREOF, AND METHODS OF USE | Jul 27, 2017 | Abandoned |
Array
(
[id] => 14406925
[patent_doc_number] => 20190169306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => CANCER AND B-CELL RELATED DISEASE THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/321367
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321367
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321367 | CANCER AND B-CELL RELATED DISEASE THERAPY | Jul 27, 2017 | Pending |
Array
(
[id] => 16305339
[patent_doc_number] => 10774117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Compositions relating to a mutant
[patent_app_type] => utility
[patent_app_number] => 15/648092
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 56
[patent_no_of_words] => 61745
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648092
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/648092 | Compositions relating to a mutant | Jul 11, 2017 | Issued |
Array
(
[id] => 12127505
[patent_doc_number] => 20180011091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'Method of Diagnosing Bacterial Infections Using Bacterial Glycoproteins'
[patent_app_type] => utility
[patent_app_number] => 15/632581
[patent_app_country] => US
[patent_app_date] => 2017-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7877
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15632581
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/632581 | Method of Diagnosing Bacterial Infections Using Bacterial Glycoproteins | Jun 25, 2017 | Abandoned |
Array
(
[id] => 13714315
[patent_doc_number] => 20170368112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => CANINE MICROBE PREPARATIONS FOR INCREASING OXYTOCIN
[patent_app_type] => utility
[patent_app_number] => 15/630787
[patent_app_country] => US
[patent_app_date] => 2017-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15630787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/630787 | Canine microbe preparations for increasing oxytocin | Jun 21, 2017 | Issued |
Array
(
[id] => 16671335
[patent_doc_number] => 20210060098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => Use of Inosine for the Treatment of T-Reg Deficiency
[patent_app_type] => utility
[patent_app_number] => 16/304747
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/304747 | Use of inosine for the treatment of t-reg deficiency | May 25, 2017 | Issued |
Array
(
[id] => 15927977
[patent_doc_number] => 20200155622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => COMPOSITIONS AND METHODS FOR DECREASING A POPULATION OF BILOPHILA WADSWORTHIA OR INHIBITING THE GROWTH THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/615760
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615760 | COMPOSITIONS AND METHODS FOR DECREASING A POPULATION OF BILOPHILA WADSWORTHIA OR INHIBITING THE GROWTH THEREOF | May 21, 2017 | Pending |
Array
(
[id] => 18544233
[patent_doc_number] => 11717565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Recombinant BCG overexpressing
[patent_app_type] => utility
[patent_app_number] => 16/500934
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 8249
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500934
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500934 | Recombinant BCG overexpressing | Apr 6, 2017 | Issued |
Array
(
[id] => 11823177
[patent_doc_number] => 20170212114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'Recombinant Borrelia Proteins And Methods Of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/481438
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7709
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481438
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/481438 | Recombinant Borrelia Proteins And Methods Of Use Thereof | Apr 5, 2017 | Abandoned |
Array
(
[id] => 15102225
[patent_doc_number] => 10472413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Anti-infective binding proteins that bind AIP2
[patent_app_type] => utility
[patent_app_number] => 15/462427
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15250
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15462427
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/462427 | Anti-infective binding proteins that bind AIP2 | Mar 16, 2017 | Issued |
Array
(
[id] => 18749365
[patent_doc_number] => 11808670
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Immunochromatographic device
[patent_app_type] => utility
[patent_app_number] => 16/081984
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 11816
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081984
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081984 | Immunochromatographic device | Mar 2, 2017 | Issued |